Facebook Linkedin Twitter
Inside Precision Medicine Sarepta Wins Key Label Expansion for DMD Gene Therapy, in Wake of Pfizer Failure 

Sarepta Therapeutics

Man with Duchenne muscular dystrophy sitting in a motorized wheelchair using power controller with degenerated hands
News & Features

Sarepta Wins Key Label Expansion for DMD Gene Therapy, in Wake of Pfizer Failure 

Malorye Branca -
0
Man with Duchenne muscular dystrophy sitting in a motorized wheelchair using power controller with degenerated hands
News & Features

Sarepta’s Gene Therapy for DMD Misses on Key Endpoint in Pivotal Trial

Malorye Branca -
0
Motor neuron connecting to muscle fiber to illustrate myasthenia gravis
News & Features

Sarepta Gets Adcomm Backing for Duchenne Gene Therapy

Malorye Branca -
0
Futuristic flight through a digital line landscape, Blue dust particle
Informatics

Real-World Data: The Secret Sauce for Rare Disease Research?

Malorye Branca -
0
Scientist holding a DNA
News & Features

Sarepta and GenEdit Ink $57M Deal for Non-Viral Gene Delivery

Malorye Branca -
0
Picture of a DNA spiral with a piece being removed by a hand holding tweezers to represent genome editing
News & Features

Epigenetic Editing Startup Chroma Medicine Launches With $125M Funding

Helen Albert -
0
Motor neuron connecting to muscle fiber to illustrate myasthenia gravis
News & Features

Sarepta Launches Gene Therapy Trial for Duchenne Muscular Dystrophy

Malorye Branca -
0
Adeno-associated virus, illustration
News & Features

AI Can Make Gene Therapy Design More Effective

Helen Albert -
0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine